Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Short-term Investments (2019 - 2023)

Historic Short-term Investments for Bioadaptives (BDPT) over the last 5 years, with Q3 2023 value amounting to $11.0.

  • Bioadaptives' Short-term Investments fell 6562.5% to $11.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $11.0, marking a year-over-year decrease of 6562.5%. This contributed to the annual value of $42.0 for FY2022, which is 7789.47% down from last year.
  • Per Bioadaptives' latest filing, its Short-term Investments stood at $11.0 for Q3 2023, which was down 6562.5% from $21.0 recorded in Q2 2023.
  • In the past 5 years, Bioadaptives' Short-term Investments ranged from a high of $3278.0 in Q1 2021 and a low of $11.0 during Q3 2023
  • In the last 5 years, Bioadaptives' Short-term Investments had a median value of $264.0 in 2021 and averaged $556.83.
  • As far as peak fluctuations go, Bioadaptives' Short-term Investments plummeted by 9630.06% in 2020, and later skyrocketed by 110793.65% in 2021.
  • Bioadaptives' Short-term Investments (Quarter) stood at $772.0 in 2019, then tumbled by 42.49% to $444.0 in 2020, then crashed by 57.21% to $190.0 in 2021, then tumbled by 77.89% to $42.0 in 2022, then plummeted by 73.81% to $11.0 in 2023.
  • Its Short-term Investments was $11.0 in Q3 2023, compared to $21.0 in Q2 2023 and $32.0 in Q1 2023.